Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors.

Piscaglia F, Cucchetti A, Benlloch S, Vivarelli M, Berenguer J, Bolondi L, Pinna AD, Berenguer M.

Eur J Gastroenterol Hepatol. 2006 Dec;18(12):1255-61.

PMID:
17099373
2.

Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index.

Benlloch S, Berenguer M, Prieto M, Rayón JM, Aguilera V, Berenguer J.

Liver Transpl. 2005 Apr;11(4):456-62. Erratum in: Liver Transpl. 2008 Mar;14(3):389.

3.

Prediction of asymptomatic cirrhosis in chronic hepatitis C patients: accuracy of artificial neural networks compared with logistic regression models.

Cazzaniga M, Salerno F, Borroni G, Ceriani R, Stucchi G, Guerzoni P, Casiraghi MA, Tommasini M.

Eur J Gastroenterol Hepatol. 2009 Jun;21(6):681-7.

PMID:
19445042
4.

Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus-infected liver transplant recipients.

Benlloch S, Heredia L, Barquero C, Rayón JM, Pina R, Aguilera V, Prieto M, Berenguer M.

Liver Transpl. 2009 Dec;15(12):1798-807. doi: 10.1002/lt.21919.

5.

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.

Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, Kench J, Farrell G, McCaughan GW, Jeffrey GP.

Clin Chem. 2005 Oct;51(10):1867-73. Epub 2005 Jul 28.

6.

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes.

Macías J, Girón-González JA, González-Serrano M, Merino D, Cano P, Mira JA, Arizcorreta-Yarza A, Ruíz-Morales J, Lomas-Cabeza JM, García-García JA, Corzo JE, Pineda JA.

Gut. 2006 Mar;55(3):409-14. Epub 2005 Aug 23.

7.

13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.

Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B.

Dig Liver Dis. 2008 Sep;40(9):743-8. doi: 10.1016/j.dld.2008.01.013. Epub 2008 Mar 12.

PMID:
18339592
8.

Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.

Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.

J Gastroenterol Hepatol. 2007 Nov;22(11):1904-8.

PMID:
17914968
9.

Prediction of cirrhosis in patients with chronic hepatitis C infection by artificial neural network analysis of virus and clinical factors.

Haydon GH, Jalan R, Ala-Korpela M, Hiltunen Y, Hanley J, Jarvis LM, Ludlum CA, Hayes PC.

J Viral Hepat. 1998 Jul;5(4):255-64.

PMID:
9751012
10.

Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study.

Poon TC, Hui AY, Chan HL, Ang IL, Chow SM, Wong N, Sung JJ.

Clin Chem. 2005 Feb;51(2):328-35. Epub 2004 Dec 8.

11.

A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.

Cross TJ, Calvaruso V, Foxton MR, Manousou P, Quaglia A, Grillo F, Dhillon AP, Nolan J, Chang TP, O'Grady J, Heneghan MA, O'Beirne JP, Burroughs AK, Harrison PM.

J Viral Hepat. 2010 Sep;17(9):640-9. doi: 10.1111/j.1365-2893.2009.01222.x. Epub 2009 Nov 17.

PMID:
19922441
12.

Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?

Cheung RC, Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR; VA HCV-001 Study Group.

J Clin Gastroenterol. 2008 Aug;42(7):827-34. doi: 10.1097/MCG.0b013e318046ea9a.

PMID:
18285716
13.

Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.

Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K.

Am J Med. 2007 Mar;120(3):280.e9-14.

PMID:
17349453
14.
15.

King's Score: an accurate marker of cirrhosis in chronic hepatitis C.

Cross TJ, Rizzi P, Berry PA, Bruce M, Portmann B, Harrison PM.

Eur J Gastroenterol Hepatol. 2009 Jul;21(7):730-8. doi: 10.1097/MEG.0b013e32830dfcb3.

PMID:
19430302
16.

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.

Myers RP, Benhamou Y, Imbert-Bismut F, Thibault V, Bochet M, Charlotte F, Ratziu V, Bricaire F, Katlama C, Poynard T.

AIDS. 2003 Mar 28;17(5):721-5.

PMID:
12646795
17.

Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.

Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P.

J Viral Hepat. 2006 Oct;13(10):659-70.

PMID:
16970597
18.

Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.

Sebastiani G, Vario A, Guido M, Alberti A.

J Viral Hepat. 2008 Mar;15(3):212-8. doi: 10.1111/j.1365-2893.2007.00932.x. Epub 2007 Dec 28.

PMID:
18179453
19.

Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation.

Rigamonti C, Donato MF, Fraquelli M, Agnelli F, Ronchi G, Casazza G, Rossi G, Colombo M.

Gut. 2008 Jun;57(6):821-7. doi: 10.1136/gut.2007.135046. Epub 2008 Jan 24.

PMID:
18218676
20.

Simple clinical variables predict liver histology in hepatitis C: prospective validation of a clinical prediction model.

Romagnuolo J, Andrews CN, Bain VG, Bonacini M, Cotler SJ, Ma M, Sherman M.

Scand J Gastroenterol. 2005 Nov;40(11):1365-71.

PMID:
16334447

Supplemental Content

Support Center